Clorox (NYSE:CLX) Stock Rating Upgraded by StockNews.com

Clorox (NYSE:CLX) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

CLX has been the subject of a number of other research reports. DA Davidson boosted their target price on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Evercore ISI dropped their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Barclays lifted their target price on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. Finally, JPMorgan Chase & Co. increased their price target on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Five investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $155.38.

Clorox Stock Down 0.6 %

Shares of CLX opened at $163.00 on Friday. Clorox has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company’s fifty day moving average is $164.24 and its two-hundred day moving average is $154.11. The firm has a market cap of $20.18 billion, a PE ratio of 56.79, a price-to-earnings-growth ratio of 3.04 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the firm earned $0.49 earnings per share. The firm’s revenue for the quarter was up 27.0% compared to the same quarter last year. Analysts forecast that Clorox will post 6.85 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Prospera Private Wealth LLC purchased a new stake in Clorox during the 3rd quarter worth approximately $27,000. Continuum Advisory LLC grew its position in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after buying an additional 138 shares in the last quarter. Innealta Capital LLC acquired a new stake in shares of Clorox during the second quarter worth approximately $30,000. Trifecta Capital Advisors LLC increased its stake in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the last quarter. Finally, Quarry LP raised its holdings in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.